SEC
SlamSEC
SearchBrowseEarnings

Amneal Pharmaceuticals, Inc.

Nasdaq:AMRX
Pharmaceutical Preparations
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(636 total)

TypeDateAccessionPeriodSize
4
Mar 5, 2026
0001628280-26-015285FORM 4
Mar 3, 2026
20.1 KB
4
Mar 5, 2026
0001628280-26-015283FORM 4
Mar 3, 2026
20.2 KB
4
Mar 5, 2026
0001628280-26-015241FORM 4
Mar 3, 2026
29.3 KB
4
Mar 5, 2026
0001628280-26-015239FORM 4
Mar 3, 2026
29.3 KB
4
Mar 5, 2026
0001628280-26-015238FORM 4
Mar 3, 2026
29.3 KB
4
Mar 5, 2026
0001628280-26-015235FORM 4
Mar 3, 2026
29.3 KB
4
Mar 3, 2026
0001628280-26-013900FORM 4
Mar 2, 2026
8.2 KB
4
Mar 3, 2026
0001628280-26-013893FORM 4
Mar 2, 2026
8.2 KB
4
Mar 3, 2026
0001628280-26-013890FORM 4
Mar 2, 2026
8.2 KB
4
Mar 3, 2026
0001628280-26-013887FORM 4
Mar 2, 2026
8.2 KB
4
Mar 3, 2026
0001628280-26-013882FORM 4
Mar 2, 2026
8.2 KB
4
Mar 3, 2026
0001628280-26-013878FORM 4
Mar 2, 2026
8.2 KB
10-K
Feb 27, 2026
0001723128-26-00001110-K
Dec 31, 2025
19.0 MB
8-K
Feb 27, 2026
0001723128-26-0000088-K
Feb 27, 2026
679.5 KB
8-K
Feb 3, 2026
0001628280-26-0047388-K
Feb 2, 2026
2.2 MB
8-K
Jan 28, 2026
0001628280-26-0038428-K
Jan 23, 2026
134.7 KB
8-K
Jan 13, 2026
0001723128-26-0000038-K
Jan 13, 2026
153.4 KB
4
Nov 19, 2025
0001628280-25-053188FORM 4
Nov 17, 2025
4.8 KB
144
Nov 17, 2025
0001949846-25-000603
—
4.1 KB
4
Nov 14, 2025
0001628280-25-052413FORM 4
Nov 12, 2025
11.6 KB
144
Nov 12, 2025
0001628280-25-051697
—
8.6 KB
10-Q
Nov 6, 2025
0001723128-25-00006210-Q
Sep 30, 2025
10.7 MB
8-K
Oct 30, 2025
0001723128-25-0000598-K
Oct 30, 2025
705.8 KB
SCHEDULE 13D/A
Oct 7, 2025
0000898432-25-000809
—
270.5 KB
SCHEDULE 13D/A
Oct 6, 2025
0000898432-25-000785
—
1.3 MB
25 filings shown

Amneal Pharmaceuticals, Inc. is an American publicly traded pharmaceutical company that develops, manufactures and distributes generics and specialty pharmaceutical products.

CEO
Patel Chintu
CFO
Konidaris Tasos